Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H12O |
| Molecular Weight | 208.2552 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(\C=C\C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=DQFBYFPFKXHELB-VAWYXSNFSA-N
InChI=1S/C15H12O/c16-15(14-9-5-2-6-10-14)12-11-13-7-3-1-4-8-13/h1-12H/b12-11+
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein. | 2015-02 |
|
| 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells. | 2013-05-25 |
|
| Rat α-Fetoprotein binding affinities of a large set of structurally diverse chemicals elucidated the relationships between structures and binding affinities. | 2012-11-19 |
|
| Inhibitory effects of aurentiacin from Syzygium samarangense on lipopolysaccharide-induced inflammatory response in mouse macrophages. | 2012-03 |
|
| Anti-tumor effects by a synthetic chalcone compound is mediated by c-Myc-mediated reactive oxygen species production. | 2010-10-06 |
|
| Chalcone inhibits the activation of NF-kappaB and STAT3 in endothelial cells via endogenous electrophile. | 2007-03-20 |
|
| Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives. | 2007-03-15 |
|
| Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans. | 2007-01 |
|
| Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006-11 |
|
| Metabolism of the alpha,beta-unsaturated ketones, chalcone and trans-4-phenyl-3-buten-2-one, by rat liver microsomes and estrogenic activity of the metabolites. | 2005-08 |
|
| Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. | 2003-10 |
|
| Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase. A new role for leukotriene B4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase. | 2001-11-02 |
|
| In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. | 2001-08 |
|
| Inhibition of HIV activation in latently infected cells by flavonoid compounds. | 1996-01-01 |
|
| Commonly occurring plant flavonoids have estrogenic activity. | 1993-07 |
|
| Aspects of the metabolism of the peripheral vasodilator mecinarone (14C-6809 MD) in rat, dog and man. | 1980 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
210-383-8
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
ALTERNATIVE | |||
|
27618
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
48965
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
637760
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
5S5A2Q39HX
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
4523
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
614-47-1
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
167107
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
202-330-2
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
DTXSID20873536
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
2592960
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
94-41-7
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
m3306
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | Merck Index | ||
|
26612
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
CHALCONE
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
D002599
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY | |||
|
5S5A2Q39HX
Created by
admin on Mon Mar 31 19:17:06 GMT 2025 , Edited by admin on Mon Mar 31 19:17:06 GMT 2025
|
PRIMARY |
ACTIVE MOIETY